Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Multiple Myeloma 43 Prostatic Neoplasms 38 Carcinoma, Non-Small-Cell Lung 35 Breast Neoplasms 32 Lymphoma 26 Leukemia, Myeloid, Acute 22 Lymphoma, Non-Hodgkin 20 Melanoma 17 Hodgkin Disease 15 Hematologic Neoplasms 15 Colorectal Neoplasms 15 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Lung Neoplasms 14 Squamous Cell Carcinoma of Head and Neck 13 Ovarian Neoplasms 12 Neoplasm Metastasis 12 Myelodysplastic Syndromes 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Sarcoma 11 Head and Neck Neoplasms 11 Triple Negative Breast Neoplasms 10 Pancreatic Neoplasms 10 Carcinoma, Renal Cell 10 Burkitt Lymphoma 10 Wilms Tumor 9 Neoplasms 9 Lymphoma, Large B-Cell, Diffuse 9 Glioma 9 Rhabdomyosarcoma 8 Rhabdoid Tumor 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Solid Tumor, Adult × 30 days × Clear all

NCT05582850 2026-05-12

EPRAD

Domain Therapeutics SA

Phase 1 Terminated

29 enrolled 12 charts

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡